These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7515192)

  • 1. Utility of fragmented human fetal tissue as a potential dopaminergic brain graft in Parkinson's disease.
    HogenEsch RI; Staal MJ; Kema IP; Buys CH; Go KG
    Stereotact Funct Neurosurg; 1993; 61(1):1-11. PubMed ID: 7515192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
    Kirik D; Björklund A
    Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.
    Mendez I; Sanchez-Pernaute R; Cooper O; Viñuela A; Ferrari D; Björklund L; Dagher A; Isacson O
    Brain; 2005 Jul; 128(Pt 7):1498-510. PubMed ID: 15872020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transplantation of fetal dopaminergic cells simultaneously to the corpus striatum and pars reticularis of the substantia nigra in hemi-parkinsonian rats].
    Blanco L; Pavón N; Alvaŕez P; Díaz C; Castellano O; Castillo L; de la Cuétara K; Macías R
    Rev Neurol; 1998 Mar; 26(151):361-5. PubMed ID: 9585942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal porcine ventral mesencephalon graft. Determination of the optimal gestational age for implantation in parkinsonian patients.
    HogenEsch RI; Koopmans J; Copray JC; van Roon WM; Kema I; Molenaar G; Go KG; Staal MJ
    Exp Brain Res; 2000 Jun; 132(3):345-50. PubMed ID: 10883382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.
    Kordower JH; Freeman TB; Snow BJ; Vingerhoets FJ; Mufson EJ; Sanberg PR; Hauser RA; Smith DA; Nauert GM; Perl DP
    N Engl J Med; 1995 Apr; 332(17):1118-24. PubMed ID: 7700284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative examination of rat and human fetal dopaminergic grafts.
    Staal MJ; Hogen Esch RI; Tomasini R; Kraayenbrink R; Kema IP; Buijs RM; Go KG; Zuiderveen F; Buys CH
    Stereotact Funct Neurosurg; 1990; 54-55():290-6. PubMed ID: 2080344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
    Törnqvist N; Björklund L; Strömberg I
    Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hitchcock's experimental series of foetal implants for Parkinson's disease: co-grafting ventral mesencephalon and striatum.
    Meyer CH; Detta A; Kudoh C
    Acta Neurochir Suppl; 1995; 64():1-4. PubMed ID: 8748573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation therapy for Parkinson's disease.
    Borlongan CV
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2319-30. PubMed ID: 11060809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral intracaudate cografting of fetal ventral mesencephalon and striatum in advanced Parkinson's disease.
    Kudoh C; Detta A; Meyer C; Byrne P; Hitchcock E
    Transplant Proc; 1999 Dec; 31(8):3397-402. PubMed ID: 10616520
    [No Abstract]   [Full Text] [Related]  

  • 12. Encapsulated cell implantation for Parkinson's disease.
    Christenson L; Emerich DF; Sanberg PR
    Mov Disord; 1992; 7(2):185-6. PubMed ID: 1584240
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplanted allogeneic fetal dopamine neurons survive and improve motor function in idiopathic Parkinson's disease.
    Widner H; Brundin P; Rehncrona S; Gustavii B; Frackowiak R; Leenders KL; Sawle G; Rothwell JC; Marsden CD; Björklund A
    Transplant Proc; 1991 Feb; 23(1 Pt 1):793-5. PubMed ID: 1990693
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on fetal transplantation: the Swedish experience.
    Lindvall O
    Mov Disord; 1998; 13 Suppl 1():83-7. PubMed ID: 9613723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immature neural tissue grafts in Parkinson's disease.
    Widner H
    Acta Neurol Scand Suppl; 1993; 146():43-5. PubMed ID: 8333253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogenesis of embryonic porcine ventral mesencephalon in the perspective of its potential use as a xenograft in Parkinson's disease.
    Molenaar GJ; Hogenesch RI; Sprengers ME; Staal MJ
    J Comp Neurol; 1997 May; 382(1):19-28. PubMed ID: 9136809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryopreservation of porcine fetal ventral mesencephalic tissue for intrastriatal transplantation in Parkinson's disease.
    Koopmans J; HogenEsch I; Copray S; Middel B; van Dijk H; Go KG; Staal M
    Cell Transplant; 2001; 10(7):573-81. PubMed ID: 11714191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells.
    Agrawal AK; Shukla S; Chaturvedi RK; Seth K; Srivastava N; Ahmad A; Seth PK
    Neurobiol Dis; 2004 Aug; 16(3):516-26. PubMed ID: 15262263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease.
    Barker RA; Barrett J; Mason SL; Björklund A
    Lancet Neurol; 2013 Jan; 12(1):84-91. PubMed ID: 23237903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell transplantation: a future therapy for Parkinson's disease?
    Lindvall O
    Neurologia; 1994 Mar; 9(3):101-7. PubMed ID: 8204256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.